- Home
- ERAS vs UFCS Comparison
ERAS vs UFCS Comparison
Compare ERAS & UFCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ERAS | UFCS |
|---|---|---|
| Founded | 2018 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 929.5M |
| IPO Year | 2021 | 1995 |
Fundamental Metrics
Financial Performance| Metric | ERAS | UFCS |
|---|---|---|
| Price | $15.51 | $37.65 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 2 |
| Target Price | $5.78 | ★ $40.50 |
| AVG Volume (30 Days) | ★ 3.3M | 119.1K |
| Earning Date | 04-30-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 2.05% |
| EPS Growth | 16.87 | ★ 87.45 |
| EPS | N/A | ★ 4.48 |
| Revenue | N/A | ★ $1,386,412,000.00 |
| Revenue This Year | N/A | $3.00 |
| Revenue Next Year | N/A | $19.26 |
| P/E Ratio | ★ N/A | $8.72 |
| Revenue Growth | N/A | ★ 10.62 |
| 52 Week Low | $1.01 | $25.01 |
| 52 Week High | $15.27 | $40.63 |
Technical Indicators
Market Signals| Indicator | ERAS | UFCS |
|---|---|---|
| Relative Strength Index (RSI) | 79.91 | 48.85 |
| Support Level | $1.27 | $37.26 |
| Resistance Level | N/A | $37.87 |
| Average True Range (ATR) | 0.82 | 1.03 |
| MACD | 0.06 | -0.10 |
| Stochastic Oscillator | 99.32 | 13.95 |
Price Performance
Historical ComparisonAbout ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About UFCS United Fire Group Inc.
United Fire Group Inc is engaged in the business of writing property and casualty insurance and selling annuities through a network of independent agencies. The company's only operating segment is property and casualty insurance, which includes commercial lines insurance, personal lines insurance, and assumed reinsurance. The primary source of revenue is premium and investment income.